Taylor Hoffman Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Taylor Hoffman Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-100	Closed	-$14K	–	227
2020 Q2	$14K	Buy	+100	New	+$12.7K	0.01%	273
2020 Q1	–	Sell	-100	Closed	-$12K	–	232
2019 Q4	$12K	Hold	100	–	–	0.01%	299
2019 Q3	$10K	Hold	100	–	–	0.01%	308
2019 Q2	$11K	Hold	100	–	–	0.01%	279
2019 Q1	$11K	Hold	100	–	–	0.01%	281
2018 Q4	$10K	Hold	100	–	–	0.01%	280
2018 Q3	$12K	Hold	100	–	–	0.01%	272
2018 Q2	$11K	Hold	100	–	–	0.01%	258
2018 Q1	$11K	Buy	+100	New	+$11.1K	0.01%	268

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Taylor Hoffman Wealth Management's IBB Position: Q3 2020 in Review

Taylor Hoffman Wealth Management sold out of iShares Biotechnology ETF (IBB) in Q3 2020, closing a stake of 100 shares — an estimated $14K sold.

Taylor Hoffman Wealth Management first reported a position in IBB in Q1 2018 and held it in 9 quarters. The position peaked at $14K in Q2 2020. 784 funds tracked by Wall St. Rank hold IBB as of Q3 2020.

Taylor Hoffman Wealth Management reported no remaining iShares Biotechnology ETF position as of Q3 2020 after selling out during the quarter.
Taylor Hoffman Wealth Management sold 100 iShares Biotechnology ETF shares in Q3 2020, an estimated $14K.
Taylor Hoffman Wealth Management first reported a position in iShares Biotechnology ETF in Q1 2018 and held it in 9 quarters.
Taylor Hoffman Wealth Management's iShares Biotechnology ETF position peaked at $14K in Q2 2020.
784 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2020.

Based on Taylor Hoffman Wealth Management's 13F filing for Q3 2020, filed 29 Oct 2020.